Stocks making the biggest moves after hours: Peloton, Oracle, Chewy & more

Market Insider

Oracle CEO Safra Catz delivers a keynote address during the 2019 Oracle OpenWorld on September 17, 2019 in San Francisco, California. Oracle CEO Safra Catz kicked off day two of the 2019 Oracle OpenWorld with a keynote address. The annual convention runs through September 19.

Justin Sullivan | Getty Images

Check out the companies making headlines after hours Thursday:

Oracle — Shares of Oracle traded 2.3% higher on the back of fiscal first-quarter results that beat analyst expectations. The software giant posted a profit of 93 cents per share on revenue of $9.37 billion. Analysts expected earnings of 86 cents per share on revenue of $9.19 billion. On an annualized basis, Oracle’s fiscal first-quarter revenue grew by 2% after dropping by 6.3% in the prior period.

Peloton — Peloton shares popped more than 7% in after-hours trading on the back of better-than-expected quarterly numbers. The fitness equipment maker posted a profit of 27 cents per share. Analysts polled by Refinitiv expected earnings per share of 10 cents per share. The company also reported a 172% surge in year-over-year sales.

Chewy — Shares of the online pet food retailer dipped 0.9% after the bell. The move came after Chewy reported new sales per active customer totaled $356 for the second quarter, which is below a FactSet estimate of $365. To be sure, Chewy’s quarterly revenue came in at $1.7 billion, topping an estimate of $1.64 billion.

Dave & Buster’s — Dave & Buster’s reported a bigger-than-expected drop in comparable sales, which sent the stock down more than 5% in after-hours trading. The company said its comparable store sales dropped 87% on a year-over-year basis in the second quarter. Analysts polled by FactSet expected a drop of 79.1%. Overall revenue for the previous quarter totaled $50.8 million, well below a forecast of $78.5 million.

Articles You May Like

What should my wife do with my Roth IRA when I die?
David Einhorn to speak as the priciest market in decades gets even pricier postelection
Gary Gensler says he was ‘proud to serve’ as SEC chair, defends his approach to crypto regulation
AI’s Dark Horse Could Become Its Crown Jewel Under Trump
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value